
The agency agreed with nearly all of the American Association for Clinical Chemistry‘s (AACC) proposed crosswalks for the Therapeutic Drug Assays.
CMS has not yet posted the final gap-fill recommendations for the molecular pathology codes.
More information to come as is becomes available.
[Source: AACC]